Preclinical toxicology of platinum analogues in dogs.

[1]  J. Mcvie,et al.  Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogue. , 1986, Cancer research.

[2]  L. V. van Putten,et al.  Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives. , 1984, European journal of cancer & clinical oncology.

[3]  S. Harland,et al.  Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma. , 1983, Cancer treatment reports.

[4]  R. Ozols,et al.  A Phase I and Pharmacokinetic Study of Diamminecyclobutanedicarboxylatoplatinum (NSC 241240) , 1983 .

[5]  L. Pendyala,et al.  Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP). , 1983, Cancer treatment reports.

[6]  B. Issell,et al.  New platinum complexes in clinical trials. , 1983, Cancer treatment reviews.

[7]  W. T. Bradner,et al.  Toxicology screening in small animals. , 1981, Cancer treatment reviews.

[8]  R. Schilsky,et al.  Toxic effects of cis-dichlorodiammineplatinum(II) in man. , 1979, Cancer treatment reports.

[9]  Michael G. K. Jones,et al.  Selection of potential second generation platinum compounds , 1978 .

[10]  Z. Pavelic,et al.  29 Dichlorodihydroxybisisopropylamine platinum IV a new antitumor platinum complex. Pharmacokinetics in the rat; relation to renal toxicity , 1978 .

[11]  J. Holland,et al.  Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors , 1974, Cancer.

[12]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[13]  J. Misset,et al.  Phase I study of cis-dichloro-trans-dihydroxy-bis(isopropylamine)platinum IV (CHIP). , 1986, Oncology.

[14]  J. Reedijk.  Nomenclature for Platinum Antitumor Compounds , 1984 .

[15]  J. Schurig,et al.  Evaluation of Platinum Complexes for Emetic Potential , 1984 .

[16]  W. Rose,et al.  Antitumor activity and toxicity of cisplatin analogs. , 1982, Cancer treatment reports.

[17]  H. Pinedo,et al.  Phase I study and pharmacokinetics of CIS-1,1-DI (amino-methyl)-cyclohexane PT II Sulphate (TNO-6) , 1982 .

[18]  W. T. Bradner,et al.  Cisplatin-induced emesis in the Ferret: a new animal model. , 1982, Cancer treatment reports.

[19]  K. Harrap,et al.  ANTITUMOR, TOXIC AND BIOCHEMICAL PROPERTIES OF CISPLATIN AND EIGHT OTHER PLATINUM COMPLEXES , 1980 .

[20]  A. Guarino,et al.  APPROACHES TO STUDIES OF PLATINATE TOXICITIES , 1980 .